Holen Sie sich die Stockscreener-App
24.80
6.73%
-1.79
Handel nachbörslich:
24.78
-0.02
-0.08%
Schlusskurs vom Vortag:
$26.59
Offen:
$26.615
24-Stunden-Volumen:
4.05M
Relative Volume:
0.75
Marktkapitalisierung:
$4.42B
Einnahmen:
$644.86M
Nettoeinkommen (Verlust:
$196.05M
KGV:
25.28
EPS:
0.9812
Netto-Cashflow:
$317.50M
1W Leistung:
-9.49%
1M Leistung:
+13.76%
6M Leistung:
-0.88%
1J Leistung:
-60.97%
1-Tages-Spanne:
$24.80
$26.70
1-Wochen-Bereich:
$24.36
$26.94
52-Wochen-Spanne:
$17.15
$76.51
Doximity Inc Stock (DOCS) Company Profile
Firmenname
Doximity Inc
Sektor
Branche
Telefon
(650) 549-4330
Adresse
500 THIRD STREET, SUITE 510, SAN FRANCISCO
Compare DOCS vs VEEV, BTSG, TEM, HQY, TXG
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
DOCS
Doximity Inc
|
24.80 | 4.45B | 644.86M | 196.05M | 317.50M | 0.9812 |
VEEV
Veeva Systems Inc
|
243.75 | 39.23B | 3.32B | 941.65M | 1.64B | 5.6161 |
BTSG
Brightspring Health Services Inc
|
61.71 | 11.81B | 13.65B | 169.86M | 412.12M | 1.0758 |
TEM
Tempus Ai Inc
|
52.10 | 9.85B | 1.36B | -302.91M | -219.93M | -1.7182 |
HQY
Healthequity Inc
|
104.73 | 8.82B | 1.34B | 230.70M | 440.96M | 2.6695 |
TXG
10 X Genomics Inc
|
56.09 | 7.52B | 638.78M | -22.66M | 122.18M | -0.1744 |
Doximity Inc Stock (DOCS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-04-20 | Herabstufung | Truist | Buy → Hold |
| 2026-04-08 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2026-02-09 | Hochstufung | Canaccord Genuity | Hold → Buy |
| 2026-02-06 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2026-01-20 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2026-01-09 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2026-01-08 | Hochstufung | Truist | Hold → Buy |
| 2025-12-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-12-09 | Eingeleitet | Barclays | Overweight |
| 2025-11-21 | Hochstufung | Raymond James | Outperform → Strong Buy |
| 2025-11-13 | Eingeleitet | BMO Capital Markets | Market Perform |
| 2025-10-27 | Hochstufung | BofA Securities | Neutral → Buy |
| 2025-10-10 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2025-10-01 | Herabstufung | Goldman | Neutral → Sell |
| 2025-07-09 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-06-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-02-07 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-07 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-11-15 | Eingeleitet | Goldman | Neutral |
| 2024-11-14 | Hochstufung | Morgan Stanley | Underweight → Equal-Weight |
| 2024-11-13 | Herabstufung | Canaccord Genuity | Buy → Hold |
| 2024-11-08 | Hochstufung | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2024-11-08 | Hochstufung | Wells Fargo | Underweight → Equal Weight |
| 2024-10-15 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-08-09 | Hochstufung | Needham | Hold → Buy |
| 2024-07-18 | Herabstufung | Wells Fargo | Equal Weight → Underweight |
| 2024-04-25 | Hochstufung | JP Morgan | Underweight → Neutral |
| 2024-02-26 | Eingeleitet | Leerink Partners | Market Perform |
| 2024-01-03 | Eingeleitet | Barclays | Equal Weight |
| 2024-01-02 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-09 | Herabstufung | Guggenheim | Buy → Neutral |
| 2023-08-09 | Herabstufung | Needham | Buy → Hold |
| 2023-08-03 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-05-01 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2023-01-06 | Herabstufung | Morgan Stanley | Equal-Weight → Underweight |
| 2022-10-31 | Eingeleitet | Wells Fargo | Overweight |
| 2022-10-24 | Eingeleitet | Evercore ISI | In-line |
| 2022-10-13 | Eingeleitet | BTIG Research | Neutral |
| 2022-09-16 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2022-09-07 | Eingeleitet | Truist | Hold |
| 2022-08-05 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-07-28 | Eingeleitet | Berenberg | Buy |
| 2022-05-18 | Bestätigt | BofA Securities | Neutral |
| 2022-05-18 | Bestätigt | Goldman | Buy |
| 2022-05-18 | Bestätigt | Guggenheim | Buy |
| 2022-05-18 | Bestätigt | Jefferies | Buy |
| 2022-05-18 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2022-05-18 | Bestätigt | Needham | Buy |
| 2022-04-07 | Eingeleitet | Guggenheim | Buy |
| 2022-04-04 | Eingeleitet | BofA Securities | Neutral |
| 2022-02-11 | Eingeleitet | Goldman | Buy |
| 2021-12-14 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2021-12-02 | Eingeleitet | Jefferies | Buy |
| 2021-11-17 | Eingeleitet | Robert W. Baird | Outperform |
| 2021-11-10 | Bestätigt | Canaccord Genuity | Buy |
| 2021-11-10 | Bestätigt | Goldman | Neutral |
| 2021-11-10 | Bestätigt | Morgan Stanley | Equal-Weight |
| 2021-11-10 | Bestätigt | Needham | Buy |
| 2021-11-10 | Bestätigt | Piper Sandler | Overweight |
| 2021-08-26 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-07-19 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-07-19 | Eingeleitet | Goldman | Neutral |
| 2021-07-19 | Eingeleitet | JP Morgan | Overweight |
| 2021-07-19 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2021-07-19 | Eingeleitet | Piper Sandler | Overweight |
| 2021-07-19 | Eingeleitet | Raymond James | Outperform |
| 2021-07-19 | Eingeleitet | SVB Leerink | Outperform |
| 2021-07-19 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Doximity Inc Aktie (DOCS) Neueste Nachrichten
Doximity (DOCS) Q1 2027 Earnings Call Transcript - AOL.com
Rapid7, 8x8, Doximity, Marqeta, and Tenable Shares Are Soaring, What You Need To Know - Yahoo Finance UK
Is Doximity (DOCS) Turning Rising AI Revenue Into Sustainable Profits Or Margin Trade-Offs? - simplywall.st
Clinical AI Use Surges as Revenue Climbs & Doctors Embrace New Tools - Streetwise Reports
The 5 Most Interesting Analyst Questions From Doximity’s Q2 Earnings Call - Yahoo Finance
DOCS Stock Soars After CEO Says Clinical AI Outperformed Anthropic, Wall Street Lifts Price Targets - Stocktwits
Doximity AI Tools Fuel Physician Engagement Growth Amid Healthcare Digital Shift - Streetwise Reports
DOCS|Doximity Inc|Price:25.030|Chg%:-1.560 - TradingKey
Doximity (NYSE:DOCS) Trading Down 5.6%Here's Why - MarketBeat
Doximity, Inc. (DOCS) Q4 2025 Earnings – Full Coverage Heather Watson (LwrmLN9W8f) - Mshale
Royal Bank of Canada Has $4.81 Million Stock Position in Doximity, Inc. $DOCS - MarketBeat
Doximity Inc (DOCS) Shares Surge 6.4% -- What GF Score of 86 Tel - GuruFocus
Doximity Doubled, Then Gave Most of It Back. Here’s Why the Market Doesn’t Trust the Rally - Yahoo Finance
Doximity, Inc. (DOCS) Stock Forecasts - ca.finance.yahoo.com
Doximity (NYSE: DOCS) insider schedules 1,770-share stock option sale - Stock Titan
Truist Lifts Doximity Target to $24 and Stays on Hold - TradingView
Truist raises Doximity stock price target on updated model By Investing.com - Investing.com Nigeria
Truist raises Doximity stock price target on updated model - Investing.com
Doximity Inc (DOCS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Is Doximity Inc (DOCS) a Bargain After 4.3% Drop? GF Value Says Undervalued - GuruFocus
Mizuho Securities Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $28 - Moomoo
Doximity director Timothy Cabral sells $293,325 in company stock By Investing.com - Investing.com India
Doximity, Inc. (DOCS) stock price, news, quote and history - Yahoo Finance UK
Doximity director Timothy Cabral sells $293,325 in company stock - Investing.com
First Trust Advisors LP Cuts Stock Position in Doximity, Inc. $DOCS - MarketBeat
Timothy Cabral Sells 7,500 Shares of Doximity (NYSE:DOCS) Stock - MarketBeat
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup - The Motley Fool
Atlassian and Doximity Just Surged 30% After Earnings: 3 Software Stocks with the Same Setup - The Motley Fool
Morgan Stanley Maintains Doximity(DOCS.US) With Buy Rating, Maintains Target Price $35 - moomoo.com
J.P. Morgan Maintains Doximity(DOCS.US) With Hold Rating, Raises Target Price to $31 - Moomoo
Doximity, Inc. (DOCS) Stock Price, News, Quote & History - Yahoo! Finance Canada
Doximity Stock Surges in Overnight Trading as Chief Executive Highlights High-Margin AI Tool - TIKR.com
DOCS Q2 Deep Dive: AI Product Adoption Fuels Revenue Growth, Margins Face Investment Pressures - Yahoo Finance
Doximity (NYSE:DOCS) Shares Gap DownHere's What Happened - MarketBeat
Wells Fargo Downgrades Doximity to Underweight From Equalweight, Price Target is $18 - marketscreener.com
Wells Fargo downgrades Doximity stock rating on valuation concerns - Investing.com
Wells Fargo downgrades Doximity stock rating on valuation concerns By Investing.com - Investing.com South Africa
Doximity, Inc. (DOCS) Stock Analysis: Navigating a 7.34% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Janus Henderson Group PLC Sells 462,468 Shares of Doximity, Inc. $DOCS - MarketBeat
Doximity (DOCS) Stock Fair Value Rises After Split Analyst Views On AI Growth - Yahoo Finance
Doximity, Inc. $DOCS Shares Purchased by Quantinno Capital Management LP - MarketBeat
DOXIMITY, INC. : RAYMOND JAMES RAISES TARGET PRICE TO $38 FROM $23 - webull.com
Doximity (DOCS) Is Up 31.0% After Raising Revenue Outlook On Clinical AI AdoptionHas The Bull Case Changed? - Yahoo Finance
Natera, Doximity, PubMatic, Airbnb And Other Big Stocks Moving Higher On Friday - Sahm
Why Doximity Stock Skyrocketed on Friday - The Motley Fool
Does Doximity’s Q1 Beat And Higher Guidance Alter The Bull Case For DOCS’ AI Platform? - webull.com
Doximity: I Called The Pop Over A Month Ago, But Now Is The Time To Wait (Rating Downgrade) - Seeking Alpha
Doximity Q1 Earnings Call Highlights - TradingView
Doximity, Inc. SEC Filing (Aug 7, 2026) - Stock Titan
Finanzdaten der Doximity Inc-Aktie (DOCS)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.20%
35.70%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):